Trial Profile
An open label study on the efficacy and safety of donepezil hydrochloride (Aricept) in vascular dementia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2012
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Vascular dementia
- Focus Therapeutic Use
- 03 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Apr 2009 Additional trial investigator Jacqueline Dominguez added as reported by ClinicalTrials.gov.
- 01 Apr 2009 Additional trial centre Eisai Inc. added as reported by ClinicalTrials.gov